🔎 Trials Near Me

Akèy › Kansè fwa

Etid klinik pou Kansè fwa ap rekrite nan Etazini

67 etid pou Kansè fwa ap rekrite patisipan nan sit atravè Etazini.

Vil ki gen plis etid

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

Collection of Blood From Patients With Cancer

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT00034216

DESTINY-PANTUMOUR04

Ap rekriteEtid obsèvasyon
Laj 18 a 130 · Tout sèks · Mizajou Sep 25, 2026 · NCT07124000

National Liver Cancer Screening Trial

Ap rekriteFaz 4
Laj 18 a 85 · Tout sèks · Mizajou Sep 25, 2026 · NCT06084234

Protoacoustic Imaging For 3D Mapping

Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07832617

A Study Evaluating a New Radiation Treatment Workflow (NGDS)

Ap rekrite
Laj 21 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07824583

Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis

Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07044362

Defining the Ablative Dose for Y-90 TARE

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07586046

CREO - Microwave Ablation Feasibility Study

Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07817147

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

Ap rekriteEtid obsèvasyon
Laj 22 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06486454

GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC

Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT04864054

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06440005

Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women

Ap rekriteEtid obsèvasyon
Laj 18 a 50 · Fanm · Mizajou Sep 2, 2026 · NCT06904365

Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 99 · Tout sèks · Mizajou Aug 24, 2026 · NCT05517811

Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07010315

Distance-Based Exercise to Preserve Function and Prevent Disability

Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07059884

Jump: MR Simulation For Radiation Therapy Master Protocol

Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 20, 2026 · NCT04545957

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT06580002

Multi-analyte Blood Test Clinical Trial

Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jul 10, 2026 · NCT05199259

An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer

Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT06342414

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.